45mg/0.5mL single-dose vials for SC injection and 130mg/26mL single-dose vials for IV infusion. “Interchangeability of Selarsdi with Stelara will further enable increased access for US patients ...

It is available in both subcutaneous injection and intravenous infusion ... at an 85% discount to the current WAC list price of Stelara to help improve patient access to high-quality biologic ...

The approved presentation is also for intravenous infusion with 130mg/26ml ... "FDA approves Selarsdi injection as interchangeable with Stelara" was originally created and published by ...

It is available in both subcutaneous injection and intravenous infusion ... at an 85% discount to the current WAC list price of STELARA to help improve patient access to high-quality biologic ...

Patients may now switch between Otulfi and Stelara without requiring a prescription ... and a 130mg/26mL single-dose vial for intravenous infusion. “Fresenius Kabi is pleased to receive this ...

Selarsdi is FDA-approved in all Stelara-equivalent forms for psoriasis ... injection and 130 mg/26 mL in a single-dose vial for intravenous infusion. Alvotech developed and produces Selarsdi ...

"The approval of TREMFYA offers an IL-23 inhibitor that has shown robust rates of endoscopic remission with both subcutaneous and intravenous induction regimens. Importantly, the fully ...

It encompasses all indications approved for the STELARA® reference product ... STEQEYMA is available in both subcutaneous and intravenous formulations. The subcutaneous injection comes in ...

The treatment is available in intravenous and subcutaneous formulations ... percent lower wholesale acquisition cost, or WAC, than Stelara. The company said this pricing strategy is expected ...

It encompasses all indications approved for the STELARA reference product ... STEQEYMA is available in both subcutaneous and intravenous formulations. The subcutaneous injection comes ...